Northwest Biotherapeutics Inc. (NWBO)
Market Open
12 Jun, 13:37
OTC PINK OTC PINK Primary 
XSTU $
0. 19
+0
+0.0748%
$
307.4M Market Cap
- P/E Ratio
- Div Yield
115,391 Volume
0 Eps
$ 0.19
Previous Close Want to track NWBO and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Northwest Biotherapeutics Inc. (NWBO) Statistics
Valuation metrics
Market Cap 307.4M
Enterprise value 390.88M
Trailing P/E (ttm) -7.33
Forward P/E -4
PEG ratio -0.09
Price/Sales (ttm) 222.84
Price/Book (mrq) -8.45
Enterprise Value/Revenue 261.11
Enterprise Value/EBITDA -6.53
Overview
Shares outstanding 1.56B
Float 1.57B
Shares short 14.14M
% Held by insiders 0.04%
% Held by institutions 0%
Average volume (10 days) 2.41M
Average volume (90 days) 3.07M
Price summary
52-Week low 0.18
52-Week high 0.37
Beta -0.77
50-Day moving average 0.22
200-Day moving average 0.24
Dividends and splits
Forward annual dividend rate -
Forward annual dividend yield -
Trailing annual dividend rate -
Trailing annual dividend yield -
5-Year annual dividend yield -
Payout ratio -
Dividend Date -
Ex-Dividend Date -
Last split factor 1:16
Last split Date 26 Sep 2012
Financials
Fiscal year
Fiscal year ends 31 Dec 2025
Most recent quarter (mrq) 31 Dec 2025
Profitability
Profit margin -29.32%
Operating margin -35.74%
Operational effectiveness
Return on assets -0.55%
Return on equity 0.62%
Income Statement
Revenue (ttm) 1.38M
Revenue per share (ttm) 0
Quarterly revenue growth (yoy) 1.91%
Gross profit (ttm) -27.41M
EBITDA -57.85M
Net income to common (ttm) -61.48M
Diluted EPS (ttm) -0.03
Quarterly earnings growth (yoy) 1.91%
Balance Sheet
Total cash (mrq) 3.04M
Total cash per share (mrq) 0
Total debt (mrq) 64.83M
Total Debt/Equity (mrq) -1.68
Current ratio (mrq) 0.07%
Book value per share (mrq) -0.02
Cash Flow
Cash flow statement -44.76M
Levered free cash flow (LFCF) -23.95M
